Origin-Independent Assembly of Kaposi's Sarcoma-Associated Herpesvirus DNA Replication Compartments in Transient Cotransfection Assays and Association with the ORF-K8 Protein and Cellular PML

ABSTRACT Six predicted Kaposi's sarcoma virus herpesvirus (KSHV) proteins have homology with other well-characterized herpesvirus core DNA replication proteins and are expected to be essential for viral DNA synthesis. Intact Flag-tagged protein products from all six were produced from genomic expression vectors, although the ORF40/41 transcript encoding a primase-helicase component proved to be spliced with a 127-bp intron. The intracellular localization of these six KSHV replication proteins and the mechanism of their nuclear translocation were investigated. SSB (single-stranded DNA binding protein, ORF6) and PPF (polymerase processivity factor, ORF59) were found to be intrinsic nuclear proteins, whereas POL (polymerase, ORF9), which localized in the cytoplasm on its own, was translocated to the nucleus when cotransfected with PPF. PAF (primase-associated factor, ORF40/41), a component of the primase-helicase tripartite subcomplex together with PRI (primase, ORF56) and HEL (helicase, ORF44), required the presence of all five other replication proteins for efficient nuclear translocation. Surprisingly, even in the absence of a lytic cycle replication origin (ori-Lyt) and any known initiator or origin binding protein, the protein products of all six KSHV core replication genes cooperated in a transient cotransfection assay to form large globular shaped pseudo-replication compartments (pseudo-RC), which excluded cellular DNA. These pseudo-RC structures were confirmed to include POL, SSB, PRI, and PAF but did not contain any newly synthesized DNA. Similar to the human cytomegalovirus system, the peripheries of these KSHV pre-RC were also found to be surrounded by punctate PML oncogenic domains (PODs). Furthermore, by transient cotransfection, the six KSHV core replication machinery proteins successfully replicated a plasmid containing EBV ori-Lyt in the presence of the Epstein-Barr virus-encoded DNA binding initiator protein, ZTA. The KSHV-encoded K8 (ORF-K8) protein, which is a distant evolutionary homologue to ZTA, was incorporated into pseudo-RC structures formed by transient cotransfection with the six core KSHV replication genes. However, unlike ZTA, K8 displayed a punctate nuclear pattern both in transfected cells and at early stages of lytic infection and colocalized with the cellular PML proteins in PODs. Finally, K8 was also found to accumulate in functional viral RC, detected by incorporation of pulse-labeled bromodeoxyuridine into newly synthesized DNA in both tetradecanoyl phorbol acetate-induced JSC-1 primary effusion lymphoblasts and in KSHV lytically infected endothelial cells.

[1]  P. Lieberman,et al.  A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator , 1996, Journal of virology.

[2]  G. Hayward,et al.  Evidence that the UL84 gene product of human cytomegalovirus is essential for promoting oriLyt-dependent DNA replication and formation of replication compartments in cotransfection assays , 1996, Journal of virology.

[3]  J M Hardwick,et al.  The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16 , 1992, Journal of virology.

[4]  E. Cesarman,et al.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. , 1995, Blood.

[5]  W. Hammerschmidt,et al.  A transcription factor with homology to the AP‐1 family links RNA transcription and DNA replication in the lytic cycle of Epstein‐Barr virus. , 1993, The EMBO journal.

[6]  D. Dorsky,et al.  Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells. , 1991, Virology.

[7]  N. Stow,et al.  Two binding sites for the herpes simplex virus type 1 UL9 protein are required for efficient activity of the oriS replication origin. , 1990, The Journal of general virology.

[8]  G. Pari,et al.  Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication , 1993, Journal of virology.

[9]  M. Challberg,et al.  Herpes simplex virus type 1 gene products required for DNA replication: identification and overexpression , 1989, Journal of virology.

[10]  D. Dorsky,et al.  Bipartite DNA-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function , 1995, Journal of virology.

[11]  W. Hammerschmidt,et al.  cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus , 1993, Journal of virology.

[12]  M. Borowitz,et al.  A New Primary Effusion Lymphoma-Derived Cell Line Yields a Highly Infectious Kaposi's Sarcoma Herpesvirus-Containing Supernatant , 2000, Journal of Virology.

[13]  M. Weitzman,et al.  Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. , 1996, Genes & development.

[14]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[15]  Paul Lieberman,et al.  A general mechanism for transcriptional synergy by eukaryotic activators , 1995, Nature.

[16]  G. Hayward,et al.  The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif , 1990, Journal of virology.

[17]  E. Brignole,et al.  Disruption of PML Subnuclear Domains by the Acidic IE1 Protein of Human Cytomegalovirus Is Mediated through Interaction with PML and May Modulate a RING Finger-Dependent Cryptic Transactivator Function of PML , 1998, Molecular and Cellular Biology.

[18]  M. Ballestas,et al.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.

[19]  D. McGeoch,et al.  Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis , 1988, Journal of virology.

[20]  S. Weller,et al.  ND10 Protein PML Is Recruited to Herpes Simplex Virus Type 1 Prereplicative Sites and Replication Compartments in the Presence of Viral DNA Polymerase , 1998, Journal of Virology.

[21]  G. Maul,et al.  Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. , 2000, Journal of structural biology.

[22]  M. Challberg,et al.  Interaction of herpes simplex virus type 1 DNA polymerase and the UL42 accessory protein with a model primer template , 1994, Journal of virology.

[23]  A. Berk,et al.  In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein , 1990, Journal of virology.

[24]  M. Challberg A method for identifying the viral genes required for herpesvirus DNA replication. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Challberg,et al.  Herpes simplex virus DNA replication: the UL9 gene encodes an origin-binding protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Hayward,et al.  The Human Cytomegalovirus IE2 and UL112-113 Proteins Accumulate in Viral DNA Replication Compartments That Initiate from the Periphery of Promyelocytic Leukemia Protein-Associated Nuclear Bodies (PODs or ND10) , 1999, Journal of Virology.

[27]  S. Kenney,et al.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Countryman,et al.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Hayward,et al.  trans-acting requirements for replication of Epstein-Barr virus ori-Lyt , 1992, Journal of virology.

[30]  D. Knipe,et al.  Assembly of herpes simplex virus replication proteins at two distinct intranuclear sites. , 1997, Virology.

[31]  D. Coen,et al.  Correct intranuclear localization of herpes simplex virus DNA polymerase requires the viral ICP8 DNA-binding protein , 1991, Journal of virology.

[32]  G. Hayward,et al.  Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays , 1995, Journal of virology.

[33]  M. Powers,et al.  Cytosolic factors in nuclear transport: What's importin? , 1994, Cell.

[34]  P. Chavrier,et al.  Both Epstein‐Barr virus (EBV)‐encoded trans‐acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. , 1986, The EMBO journal.

[35]  D. Reisman,et al.  A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Countryman,et al.  Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras , 1996, Journal of virology.

[37]  G. Hayward,et al.  Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region , 1985, Cell.

[38]  F. Bischoff,et al.  Export of Importin α from the Nucleus Is Mediated by a Specific Nuclear Transport Factor , 1997, Cell.

[39]  S. Weller,et al.  Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments , 1997, Journal of virology.

[40]  S. Kenney,et al.  The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators , 1989, Journal of virology.

[41]  A. Davison,et al.  Genetic relations between varicella-zoster virus and Epstein-Barr virus. , 1987, The Journal of general virology.

[42]  B. Barrell,et al.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. , 1990, Current topics in microbiology and immunology.

[43]  P. Schaffer,et al.  Herpes simplex virus type 1 ICP27 is an essential regulatory protein , 1985, Journal of virology.

[44]  P. Elias,et al.  Characterization of a binding site for the herpes simplex virus type 1 UL9 origin-binding protein within the UL9 gene. , 1996, The Journal of general virology.

[45]  L. Szekely,et al.  Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies. , 1999, The Journal of general virology.

[46]  R. S. Tan,et al.  Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity , 1987, Journal of virology.

[47]  J. Sample,et al.  The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions , 1990, Journal of virology.

[48]  S. Weller,et al.  Formation of herpes simplex virus type 1 replication compartments by transfection: requirements and localization to nuclear domain 10 , 1997, Journal of virology.

[49]  G. Maul,et al.  The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition , 1996, The Journal of cell biology.

[50]  E. Flemington,et al.  ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter , 1991, Journal of virology.

[51]  B. Chandran,et al.  Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. , 1998, Virology.

[52]  L. J. Perry,et al.  Structures of herpes simplex virus type 1 genes required for replication of virus DNA , 1988, Journal of virology.

[53]  C. Boshoff,et al.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.

[54]  R. Sun,et al.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  W. Hammerschmidt,et al.  Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus , 1988, Cell.

[56]  H. Kung,et al.  Kaposi’s Sarcoma-Associated Herpesvirus Encodes a bZIP Protein with Homology to BZLF1 of Epstein-Barr Virus , 1999, Journal of Virology.

[57]  G. Maul,et al.  Human Cytomegalovirus Immediate Early Interaction with Host Nuclear Structures: Definition of an Immediate Transcript Environment , 1997, The Journal of cell biology.

[58]  T. Daikoku,et al.  Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3'-to-5' exonucleolytic activity and stability of initiation complex at primer terminus , 1994, Journal of virology.

[59]  Sarah Nikiforow,et al.  Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50/Rta Protein Activates the Entire Viral Lytic Cycle in the HH-B2 Primary Effusion Lymphoma Cell Line , 2000, Journal of Virology.

[60]  R. Sun,et al.  Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells , 1997, Journal of virology.

[61]  T. Kouzarides,et al.  Epstein‐Barr virus BZLF1 trans‐activator specifically binds to a consensus AP‐1 site and is related to c‐fos. , 1989, The EMBO journal.

[62]  S. Kenney,et al.  The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner , 1990, Journal of virology.

[63]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[64]  F. Zhu,et al.  Identification of the Immediate-Early Transcripts of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.

[65]  O. J. Semmes,et al.  Accumulation of Epstein-barr Virus Protein and Increases Cytoplasmic Mta Has Properties of an Rna Export , 1998 .

[66]  F. Bischoff,et al.  Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. , 1997, Cell.

[67]  M. McGrath,et al.  Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.

[68]  L. Zhong,et al.  Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays , 1997, Journal of virology.

[69]  A. Berk,et al.  A mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA--promoter DNA complex formation. , 1994, Genes & development.

[70]  G. Hayward,et al.  Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures , 1995, Journal of virology.

[71]  F. Sigaux,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.

[72]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[73]  O. J. Semmes,et al.  The Epstein-Barr Virus Lytic Transactivator Zta Interacts with the Helicase-Primase Replication Proteins , 1998, Journal of Virology.

[74]  T. Ragoczy,et al.  The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes , 1998, Journal of Virology.

[75]  D. Knipe,et al.  Functional order of assembly of herpes simplex virus DNA replication proteins into prereplicative site structures , 1996, Journal of virology.

[76]  M. Carey,et al.  Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA , 1992, Journal of virology.

[77]  M. Reitz,et al.  A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins , 1997, Journal of virology.

[78]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma , 1996, Journal of virology.

[79]  C. Crumpacker,et al.  Localization of the herpes simplex virus type 1 65-kilodalton DNA-binding protein and DNA polymerase in the presence and absence of viral DNA synthesis , 1990, Journal of virology.